DFC, IFC, EIB, and AFD Boosting COVID-19 Vaccine Production in Africa with Senegal-based Vaccine Manufacturer IPD
U.S. International Development Finance Corporation (DFC), International Finance Corporation (IFC), European Investment Bank (EIB), and AFD, the French Development Agency today announced their commitment to support Fondation Institut Pasteur de Dakar (IPD), a vaccine manufacturer in Senegal, to bolster the production of COVID-19 vaccines in the country.
DFC is proud to highlight our commitment to IPD, as part of our effort under President Biden’s leadership to support vaccine manufacturing capacity across the globe. With COVID-19 cases on the rise in Africa, this critical investment in vaccine manufacturing capacity in Senegal could not come at a better time,” said David Marchick, DFC’s Chief Operating Officer. “Working with the IFC and European partners, our contribution will boost COVID-19 vaccinations on the African continent and contribute to long-term health and prosperity.
The investment in IPD represents DFC’s third investment in boosting global vaccine manufacturing. DFC’s effort is a core part of the Biden Administration’s effort to boost manufacturing in multiple regions, in large and small countries and with different technologies. It also aligns with the Administration’s COVID-19 Global Response and Recovery Framework. DFC’s support for this project also builds on collaborative work with the National Institutes of Health and the Centers for Disease Control and Prevention, which have a longstanding relationship with IPD.
Photo courtesy of Army Medicine.